Apellis Pharmaceuticals, Inc. drugs

2 results
  • empaveli - pegcetacoplan injection, solution

    (Pegcetacoplan)
    Apellis Pharmaceuticals, Inc.
    Empaveli is a complement inhibitor for adults with paroxysmal nocturnal hemoglobinuria (PNH), and for adults and patients aged 12 and older with C3 glomerulopathy (C3G) or primary immune-complex membranoproliferative glomerulonephritis (IC-MPGN) to reduce proteinuria.